Patient Inclusivity: How to Integrate Patient Voices, and Experiences for Improved Decision Making Across the Lifecycle of a Drug
Ursula Mann
Principal and Chief Patient Officer (CPO)
PatientVoicePartners
Andrew Spiegel, Esq.
Chief Executive Officer
Global Colon Cancer Association
Lisa Machado
Executive Director
Canadian CML Network
Farah Meghji
Patient Experience
Roche Canada
- Defining patient centric and patient inclusivity
- How to avoid tokenism in your approach to patient engagement
- Determining how and when manufacturers should engage patients
- Identifying methods of engagement that empower patients to share challenges and co-create solutions
- Exploring mechanisms to engage patients where pathways including POs are not available for specific conditions and disease areas
- Sharing examples of what meaningful patient engagement looks and feels like
- Applying patient insights from pre to post launch for improved decision making and patient experiences, and health outcomes
- How to measure the impact of inclusivity on health outcomes and patient experiences